Alogliptin - Wikipedia

Alogliptin (trade name Nesina and Vipidia) is an oral anti-diabetic drug in the DPP-4 inhibitor (gliptin) class. Alogliptin does not decrease the risk of heart attack ...

Alogliptin: Indications, Side Effects, Warnings - Drugs.com

Easy-to-read patient leaflet for Alogliptin. Includes indications, proper use, special instructions, precautions, and possible side effects.

Alogliptin Uses, Side Effects & Warnings - Drugs.com

Physician reviewed alogliptin patient information - includes alogliptin description, dosage and directions.

Alogliptin - pro.medicin.dk – information om medicin

Pro.medicin.dk er en hjemmeside og database, der indeholder information om lægemidler og behandlingsvejledninger til læger, farmaceuter og andre ...

Alogliptin: MedlinePlus Drug Information

Alogliptin: learn about side effects, dosage, special precautions, and more on MedlinePlus

Alogliptin Oral : Uses, Side Effects, Interactions ...

Find patient medical information for Alogliptin Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

ALOGLIPTIN | Drug | BNF content published by NICE

Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for ALOGLIPTIN.

Vipidia - pro.medicin.dk – information om medicin

Alogliptin er en kraftig og selektiv hæmmer af dipeptidylpeptidase-4, og dermed hæmmes enzymets hydrolyse af inkretinhormoner. Insulinfrigørelsen øges, og ...

Alogliptin

Min.medicin.dk er en hjemmeside om medicin, sygdomme, undersøgelser og behandling skrevet i et let tilgængeligt sprog. Oplysningerne er målrettet dig, der er ...

Alogliptin tablets for diabetes (Vipidia) | Medicine | Patient

Alogliptin will help to reduce blood sugar (glucose) levels in people with type 2 diabetes. It is often taken alongside other antidiabetic medicines.